Pivotal data at ats 2021 show dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children

Pivotal d ata at ats 2021 s how dupixent ® (dupilumab) s ignificantly r educed a sthma a ttacks and i mproved l ung f unction in c hildren

REGN Ratings Summary

REGN Quant Ranking